DEA Rescheduling Paves Way for Cannabis Processors in Pharma and Biotech Image Cannabis News May 30, 2024 DEA Rescheduling of Marijuana to Schedule III Sparks Major Opportunities for Cannabis Processors. The impending DEA rescheduling of marijuana to a Schedule III controlled substance presents a momentous opportunity for state-licensed cannabis processing businesses to diversify revenue streams Cannabis Technology News Medical Cannabis News Marijuana Business News PR Newswire